macromolecules evaluated as extenders, in order of increasing potency, were fibrinogen, albumin, succinylated polylysine, and ribonuclease A. From comparative testing, we found that antiglobulin raised the titer of antibody from 2560 to 20 480, and the avidin-biotin tool raised the titer of caproylamidobiotin-antibody from 2560 to 10 240 without extender and to 81 820 with an extender of caproylamidobiotin-ribonuclease.
Thus noncovalent extenders add to the capability of the avidin-biotin system to facilitate and substitute for an antibody.
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immunoassay
Avid in is a protein found in egg white that binds four molecules of the vitamin biotin specifically and very strongly. The dissociation constant per site has been reported by Green to be iO' mol/L (1). This binding interaction also is stable at extreme pH values and in the presence of several denaturing agents, proteolytic enzymes, and organic solvents (2) . For these reasons, but even more so because at least some of this binding persists when biotin is attached to another molecule, the avidin-biotin system has attracted interest as a general molecular binding tool. Probably the earliest applications were the inhibitions of certain enzymes by avidin, showing that biotin was necessary for their activity (3) . Several researchers more recently have used the avid in-biotin system to develop useful binding interactions, mostly in a variety of cell-labeling studies and affinity-isolation techniques, as have been recently reviewed or summarized (4) (5) (6) .
Among the several studies of the avidin-biotin tool already reported by other groups, in two instances there was evaluation in regard to antibodies.
Bayer et al. attached biotin to an anti-erythrocyte antibody, as well as antiserum, and showed that sequential treatment of erythrocytes with either of these reagents, followed by addition of a covalent conjugate of avidin and ferritin, gave specific labeling of the cell surface (7) . Similarly, Heggeness and Ash used biotin-labeled antimyosin antibody in conjunction with a fluorescein-labeled avidin to stain intracellular myosin (8) . They compared the staining characteristics with those of a conventional approach involving a fluorescein-labeled antiglobulin (indirect immunofluorescence) and reported them to be the same. What clearly emerged from both of these qualitative studies is that avidin and biotin can facilitate and partly substitute for some of the routine applications of antibodies.
In this paper, we report a different application of the avidin-biotin tool in conjunction with antibodies, namely, the immune agglutination of erythrocytes. We demonstrate that the use of molecules we call "extenders" can render the avidin-biotin system more potent than a conventional antibody. For comparison and control purposes, we also agglutinate biotin-modified cells with avidin, a capability reported previously (9, 10) . Overall, we use this agglutination system as a model to characterize some of the useful features as well as shortcomings of avidin and biotin as a tool.
Materials and Methods
We obtained sheep erythrocytes from Microbiological Associates, Bethesda, MD 20014, and human .erythrocytes from an apparently normal volunteer. Before use, these cells were washed three times with phosphate-buffered saline (0.01 mol of sodium phosphate and 0.15 mol of sodium chloride per liter, pH 7.4) and made up to 15 mL of cells per liter (11) . Avidin (A5759), d-biotin, fibrinogen (bovine fraction 1, P4000), albumin (bovine, A4378), and 2-(4'-hydroxyazobenzene)benzoic acid were from Sigma Chemical Co., St. (12) . The proteins were used as received.
Agglutination Procedures
The general sequence (with exceptions as noted) for the agglutination reactions was as follows: (a) Add 0. to 1+ (about 20% agglutination) and w (weak, about 5% agglutination).
We observed agglutination as cell clumping (aggregates involving many cells) in all cases. All titer end points were required to be 1+ or higher. Because each experiment typically comprised 150-250 tubes, and all additions of a given reagent were made before mixing, mixing was carried out anywhere from 1 to 20 mm after reagent addition. All of these steps, except (b), were carried out at room temperature.
The blanks routinely included in each procedure were as follows: no Ab, Ab, Ab + Ab', Ab + Av, Ab + Av + ExtB, AbB + Ext (no B), and AbB + Ab'.
Synthesis of Caproylamidobiotin-Nhydroxysuccinimide Ester
Suspend biotin-N-hydroxysuccinimide [340 mg, 1 mmol, synthesized as described (13) yield was 240 mg (61%) and the uncorrected melting point was 149-152 #{176}C (d); the product gave a single spot when checked by thin-layer chromatography.
Avidin Dilutions and Saturation with Biotin
The stock solution of avidin was 5 g/L of phosphate-buffered saline. (14) , and assay the avidin binding with 2-(4'-hydroxyazobenzene)benzoic acid (15) . Similarly, modify each protein with a 10-fold lower amount of caproylamidobiotin-N-hydroxysuccinimide ester in the same volume of dimethylformamide, and modify the antibody and fibrinogen with the corresponding molar excesses of biotin-N-hydroxysuccinimide ester.
Treat with 8.0 mg of biotin-N-hydroxysuccinimide dissolved in 0.1 mL of dimethylformamide 1 mL of a 10 g/L solution of polylysine in phosphate-buffered saline that has been dialyzed against phosphate-buffered saline. Treat a control with 0.1 mL of dimethylformamide.
After rotation for 1 h at room temperature, dialyze the solutions against three changes of phosphate-buffered saline (1 L each) for 24 h at 4 #{176}C, and then dilute to 5 g/L. Add sufficient sodium succinate to the solutions to make them 0.1 mol/L. Add succinic anhydride (7 mg; 100-fold molar excess over amino groups) in three aliquots over a period of 1.5 h Keep the pH at approximately 7.5 by the addition of NaOH (5 mol/L). Then dialyze the solutions against phosphate-buffered saline for 36 h.
Results
Because avidin will combine with four unconjugated or The agglutination schemes we tested and compared are shown in Figure 1 . The biotmnyl residues involved were nearly always caproylamidobiotin groups covalently introduced onto the erythrocytes and macromolecules with the reagent shown in Figure 2 . In the "direct" schemes the caproylamidobiotmn residues were attached directly to the surface of the cells, and the cells were then washed with buffer. The "indirect" approach was characterized by initial reaction of the cells with caproylamidobiotin-modified antibody.
All subsequent additions in both cases then were performed without intermediate washing steps.
The absence of further washing potentially created a more complex system when successive components were added, because reactions could take place both on the cell surface and in the bulk solution.
However, this approach was analogous to the usual utilization of antiglobulin, was convenient, and minimized damage to the cells from repeated washing steps. and when results were obtained where bulk reactions might have been important, analogous experiments were carried out with washing after every addition step.
The schemes in Figure 1 merely indicate in simplest terms the intended binding interactions.
In this paper we show that the final structural details of the intercellular binding that actually developed in the agglutination mixtures depend critically on avidin-biotin interaction, but do not characterize it further.
One of the potential advantages of the avidin-biotin system is the opportunity to involve a variety of molecules in a binding process merely by attaching biotin to these molecules. In this application, we choose to call such molecules "extenders" and utilize the agglutination model to assess several structures of extenders.
The because of the irreproducibility of the numbers and the un- 20- to 4000-fold greater, than the corresponding amounts used in the agglutination assays. This is in spite of the net negative charge of the erythrocyte surface, due mostly to sialic acid, and the highly basic nature of avidin (p1 = 10.5). Nevertheless, the charge on these sialyl residues is contributed by carboxyl groups, which have only a weak ion-exchange capacity, and certainly some competition is provided by the saline content of the buffer. Glass commonly adsorbs basic solutes strongly, and avidin is no exception. The limited ability of silanization to overcome adsorption (Table 2 ) might arise from the limited coverage of surface silanols that silanization achieves (16) . Polyethylene shows a comparable ability to adsorb avidin. Because the final amounts of avidin in our agglutination mixtures were in the low-microgram range, where adsorption losses were as high as 10%, the cited concentrations of avidin in these solutions represent upper limits only. The results from the direct and indirect agglutination schemes are summarized in Table 3 . These data, for the most part, are the consequence of extensive optimization studies in which the concentrations of the agglutinating components were independently varied to give a maximum titer. The exceptions to this are the standard amount of cells, and the somewhat arbitrary dose of BN-hydroxysuccmnimide in the direct scheme at the bottom of Table 3 .
No difference in agglutination titer was seen, whether the antibody, extender, or cells were modified with the N-hydroxysuccinimide ester of caproylamidobiotin or of biotin. For the sake of consistency, however, we used caproylamidobiotin for nearly all of the results reported in this paper. The polylysine-biotmn conjugate was found to give nonspecific agglutination;
to prevent this, the conjugate was further reacted with succinic anhydride to yield "SuPolysB."
The agglutination end points were scored visually, the reliability of which was confirmed in some of the early experiments by correlation with microscopic evaluation. The data were collected over a period of several months, involving new lots and new preparations of all biological reagents (except Ab and AbB), and the results were remarkably reproducible.
The ability of agglutination systems to perform in this manner has been noted by others (17) . In all cases in which avidin was present, some thin smearing of the cells was observed on the sides of the glass tubes, whether agglutination was occurring or not. This smearing did not constitute agglutination when it was dislodged from the surface. An analogous observation is the report by Taylor that salmine accelerates cell adhesion to glass (18) . The amplification factor in Table 3 is derived from the cited dilutions of primary reagent with and without helper. Thus, the amplification is considered to be the ability of the helper (as defined in Table 3 ) to extend the titer of the primary reagent. An extension by 8-fold is typical for the indirect agglutination of unfixed antibody-treated erythrocytes with an antiglobulin.
Erythrocytes and Test Tubes
As shown, the agglutination titer of the primary antibody was unchanged (2560) after conjugation with caproylamidobiotin at an effective concentration. Avidin alone extends the titer of AbB from 2560 to 10 240, which is less amplification than the titer of 20 480 with antiglobulmn. However, the further addition of an extender provides higher titers up to a value of 81 820 when this reagent is RNaseB.
Agglutination and qualitatively similar extension with ExtB was also possible in a direct scheme (Table 3) . Incidentally, antiglobulin extended the titer of AbB and Ab to the same extent. Table 4 shows the dependence of agglutination on the concentration of avidin. For both the direct and indirect schemes, the lowest effective avidin concentration was in the range of 0.5 to 5 mg/L. In most cases, the ability to inhibit the agglutination reaction with an excess of avidin also was established.
This result certainly is consistent with a specific agglutination mechanism. 'This agglutinatIon 'titer" was obtained by addIng 2 iL of a freshly prepared 18 g/L solution of BN-hydroxysucclnlmlde In dimethyltormamide to 10 ml of a 15 mL/L suspension of sheep erythrocytes, incubating for 30 mm at 37 #{176}C, washing the cells three times with phosphate-buffered saline-bovine serum albumin. diluting to 10 ml. dispensing 0.2 mL into a tube, adding0.1 mL of avldin solution (10 mg/L In phosphate-buffered saline-bovine serum albumin), mixing, adding 0.02 mL of EXtB (10 mg of RNaseB or 30 mg of SuPolysB. per liter, In phosphate-buffered saline-bovine serum albumin), mixing, centrifuging, resuspending, and scoring. Table 3 .
Table 4. Dependence of Agglutination on the Concentration of Avidin
b The cited values are the amounts tested. The values in parenthesesgaveagglutination.The amount of ExtB throughout was 0.6 big/tube for FibB, 0.5 for AlbB, and 0.2 for RNaseB. These values were especially optimum for the indirect agglutination at an end-point amount of AbB, and roughly optimum for the direct cases.
C For these series, steer erythrocytesB were aliquoted from a suspension of 10 mL of steer erythrocytes (15 mL/L) treated with 40 tL of afresh 0.04 zmoI/L solution of 4HS in dimethylformamide.
' As in C except 10 ML of BN.hydroxysuccmnlmlde solution was used. Essentially the same results were also obtained at 0 #{176}C. a As in cexcept 2 iL of BN-hydroxysuccmnimide solution was used. Essentially the same results were also obtained at 0 #{176}C.
'Ab dilution was 1/5120, which was one dilution past the titer of 1/2560 where Abalone agglutinated the cells. QThe end point [AbBI In each case is the titer cited in Table 3 .
the other extenders, some size heterogeneity due to an inbroader for FibB than RNaseB, whereas the latter provides herent tendency to form polymers, or some other aspect of this a greater degree of amplification at its optimum concentration. preparation is not defined. The contrasting behavior for FibB Indeed, the extended end point with RNaseB is very sharp. is documented further in Figure 3 . Table 4 , are similarly sharp.
A final point in regard to Table 4 is the behavior in agglutination at an intermediate amount of BN-hydroxysuccinimide for the avidin concentrations of 50 and 100 mg/L. Aside from the contrary behavior of the FibB, the extenders all provide agglutination at a dose of avidin that is inhibiting in their absence. Here, it is likely that the caproylamidobiotin on the cells is fully reacted with avidin, and the extender then bridges the cells together.
Such a mechanism would be expected to persist at higher avidin concentrations, once excess avidin is washed away, because such washing would prevent any consumption of added extender by residual avidin in the bulk-solution phase. This was found to be the case. When biotin conjugated to sheep erythrocytes was reacted with 500 mg of avidin per liter, washed, and treated with extender, we observed 4+ agglutination. Several types of control experiments were carried out to assure both the specificity of the agglutination enhancement by avidin and biotin and the validity of the general characteristics of this system developed with this model. These experiments and their results are summarized in Table 5 .
of the avidin with biotin either before or after addition of avidin to the system, reduced agglutination to the background level for the types of sequences being evaluated.
Controls
B and E further demonstrated the absence of nonspecificity in the AbB reagent. In B, human cells were used in place of sheep cells; adsorbed AbB was tested in E. Taken  together with the results from Table 4 , which show inhibition of agglutination at higher avidin concentrations, and the several blanks routinely included in all of the assays, these results constitute strong evidence for the critical dependence of agglutination enhancement Ofl the intercellular development of bonds among avidinand biotin-conjugated molecules.
Discussion
It is interesting to consider why the term "tool" has arisen for the avidin-biotin system. This term also has been adopted for lectins, another class of binding proteins (19) . Perhaps the intention is two-fold: first, these types of systems can be used to probe and explore chemical and biological systems; secondly (with some overlap), they will be useful for the physical manipulation of other molecules and of microscopic materials such as organelles and cells. The work reported in this paper is intended to be relevant to both viewpoints. A discussion of some characteristics of the avidin-biotin system should help its development into a well-defined probe and demonstrate its ability to manipulate cells in conjunction with antibodies.
We consider that the avidin-biotin system is advantageous as a tool not so much because of any special capability, but because of a variety of features whose relative importance will vary with the application.
Sometimes, in fact, some of these properties are likely to be undesirable, and an alternative molecular-binding system will be more appropriate. Currently established properties of avidin and biotin that are relevant (24) . However, these differences probably tend to become blurred when multivalent interactions become available, which greatly increases apparent affinity constants (25); i.e., the binding becomes avidity rather than affinity (22) . Another consideration that might reduce the effect of differences in these affinity constants in practice is the occurrence of a weaker link or a more critical parameter elsewhere in a given system. Finally, for the particular case of avidin, it is not fully clear how much of the affinity for biotin is retained when biotin is conjugated to a macromolecule. The general impression that the affinity is just as strong could relate in some cases to avidity effects. At least, it is reported that the carboxyl group of biotin can be modified with minimum (26) or apparently minimum (27) change in binding to avidin, and avidin-affinity columns can bind biotin enzymes very strongly (28) . However, a dissociation rate constant approximately 104-fold higher than the corresponding rate constant for biotin was reported for an analogous spin-label derivative of biotin (29) . Although a complex of avidin with biotinyl-hexaglycyl-1-(1-naphthoxy)-3-N-(ethylamino)-propan-2-ol was found to undergo no measurable dissociation at 4 #{176}C during a 2-h incubation, at 25 #{176}C and 37 #{176}C the half-life was 15.5 and 2 h, respectively (30) . A control experiment with a complex of biotin with avidin showed no measurable dissociation after 3 h at 37 #{176}C. Thus, additional work may be needed on this general aspect of the affinity of avidin for biotin conjugates.
In this context, it is interesting that the lowest concentration of concanavalin A that agglutinates unfixed erythrocytes is typically 1-10 mg/L (21, 31) , which is in the same range as the lowest agglutinating dose of avidin (direct or indirect, with or without extender) in this study. It might be useful to know the number of receptors involved in each case (this number is not defined in our work) before drawing conclusions. However, the total number of concanavalin-A-binding sites inthe work citedearlier (involvingerythrocytes synthetically modified with mannose residues) was reported not to correlate with the extent of concanavalin-A-induced agglutination (21) . Thus it maybe necessary to invoke one or more of the factors cited above for blurring affinity differences to account for this comparable potency in cellular agglutination of a "very weak" and "very strong" binding agent.
Alternatively, it is conceivable that any lower affinity of the specific binding in the lectin-sugar system relative to the avidin-biotin system actually could be favorable for cellular agglutination.
This might arise from the greater reversibility of the weaker lectin bonds. For example, concanavalin A might be comparable to avidin in achieving agglutination because this lectin is more able to switch from intracellular to intercellular binding when the cell surfaces are in contact.
A second feature of our agglutination work, which can be compared with lectin agglutination and which may similarly relate to the affinity differences between avidin and lectins, is the agglutination behavior at a high concentration of binding protein.
The agglutination of mannose-modified erythrocytes cited here earlier (21) persisted even at concanavalin A concentrations near 500 mg/L (32). The agglutination of native erythrocytes with lectins persists as well at very high concentrations of lectin (33) . In contrast, we observed sharp and total inhibition of agglutination with avidin at concentrations as low as 5 to 100 mg/L, depending upon the nature and amount of the other reagents (see Table 4 ). Perhaps a weaker lectin-receptor binding leads to significantly less saturation of receptors and (or) renders the saturation of the receptors more reversible than with avidin, so that a greater shift to intercellular binding occurs with the lectin when the cells are brought together. An alternative speculation is that "nonspecific" qdhesion develops at the greater concentrations of lectin. Avidin was only half as able as antiglobulin to extend the titer of its primary reagent, as defined and summarized in Figure 3 . Each of these agents might therefore be preferred in a given system, depending on the experimental objective. conditions, a basic advantage for this system that has been cited previously (9) . This agglutination system also posed some limitations. Cellular agglutination is a complex phenomenon for which a variety of factors have been considered to play a role (19, 34) . This placed some limits on the degree to which our model could be used to reveal and develop characteristics of the avidin-biotin system. Along these lines, it was important to maintain constant conditions and procedures and to use extensive controls to assure the primary dependence of the system on the specificinteractionof avidin and biotin.
One factor that may have influenced some of the results, and which has received much attention in agglutination studies, is receptor movement, cited by various authors as both promoting and inhibitingcellularagglutination (34) . We considered, for example, whether the reduced ability of avidin to achieve agglutination in the presence of extender rather than in its absence, for both the direct and indirect cases as seen in the right column of Consequently, the mechanism may involve simply an occupancy of some of the avidin sites, without intercellular cross-linking, by the extender. The amplification that extender provides then proceeds to develop optimally at a higher avidin concentration than in the absence of extender. Analogously to our observation that the extent of direct agglutination without extender is the same at 0#{176}C and at room temperature, Schnebli and B#{228}chi observed no change in the extent of agglutination of erythrocytes by concanavalin A over the same temperature change (33) . Already established as a universal binding system, the avidin-biotin tool is seen here to gain in versatility in conjunction with antibodies by the involvement of noncovalent extenders. We expect that other applications of this tool also will benefit by the use of such extenders.
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